Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Integrative analysis of pooled CRISPR screens provide functional insights into AD GWAS risk genes

Summary Microglia pathways such as lipid transport and metabolism, phagocytosis, and lysosomal function are implicated Alzheimer’s disease (AD) pathology, but the mechanisms underlying these pathways remain poorly understood. To map these pathways, custom CRISPR activation and interference (CRISPRa/i) libraries were co...

Rebecca Y. Wang, Glenn Wozniak, Xiao-Ting Wang et al. · 0 citations
Clinical trial Open access Oct 2026

Phase 3 randomized trial of latozinemab in frontotemporal dementia due to GRN mutations

Abstract INTRODUCTION Heterozygous progranulin gene mutations causing frontotemporal dementia (FTD‐GRN) are associated with deficiency in progranulin (PGRN). Latozinemab is a human monoclonal immunoglobulin G1 (IgG1) antibody designed to elevate PGRN levels in people with heterozygous loss‐of‐function (LOF) GRN mutatio...

Adam Simmons, B. Boeve, I. Le Ber et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.